Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Open|February 8, 2024
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registryEnriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2021
Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes StatisticsTheresa Burkard, Marlene Rauch, Susan S Jick, et al.
BMJ Open|September 17, 2022
Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohortEnriqueta Vallejo-Yagüe, Theresa Burkard, Raphael Micheroli, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 5, 2021
The association between bariatric surgery and cataract: a propensity score-matched cohort studyTheresa Burkard, Dag Holmberg, Anders Thorell, et al.
Plos Computational Biology|June 2, 2023
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDsMaria Kalweit, Andrea M Burden, Joschka Boedecker, et al.
Applied Clinical Informatics|September 26, 2025
Best Practices to Design, Plan, and Execute Large-Scale Federated Analyses-Key Learnings and Suggestions from a Study Comprising 52 DatabasesTheresa Burkard, Montse Camprubi, Daniel Prieto-Alhambra, et al.
European Journal of Gastroenterology & Hepatology|April 22, 2021
Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBaseKaleen N Hayes, Theresa Burkard, Stefan Weiler, et al.
Menopause (New York, N.Y.)|March 20, 2019
Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive studyTheresa Burkard, Manon Moser, Marlene Rauch, et al.
BMJ Open|March 16, 2022
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in SwitzerlandTheresa Burkard, Enriqueta Vallejo-Yagüe, Thomas Hügle, et al.
Osteoarthritis and Cartilage Open|April 21, 2026
The risk of acute thromboembolic cardiovascular events in association with use of chondroitin sulphate: A comparative, propensity score-matched cohort study using Swiss healthcare claims dataTamino Zappalà, Theresa Burkard, Carola A Huber, et al.
Pageof 3